Biodesix (BDSX) Debt to Equity (2019 - 2025)
Historic Debt to Equity for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to -$27.36.
- Biodesix's Debt to Equity fell 221043.5% to -$27.36 in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.36, marking a year-over-year decrease of 221043.5%. This contributed to the annual value of $1.74 for FY2024, which is 8600.68% down from last year.
- Per Biodesix's latest filing, its Debt to Equity stood at -$27.36 for Q3 2025, which was down 221043.5% from $41.11 recorded in Q2 2025.
- In the past 5 years, Biodesix's Debt to Equity ranged from a high of $41.11 in Q2 2025 and a low of -$30.61 during Q3 2023
- For the 5-year period, Biodesix's Debt to Equity averaged around $0.25, with its median value being $1.5 (2021).
- Per our database at Business Quant, Biodesix's Debt to Equity soared by 408049.32% in 2021 and then tumbled by 221043.5% in 2025.
- Quarter analysis of 5 years shows Biodesix's Debt to Equity stood at $1.41 in 2021, then rose by 21.91% to $1.72 in 2022, then soared by 626.61% to $12.46 in 2023, then tumbled by 86.01% to $1.74 in 2024, then tumbled by 1668.7% to -$27.36 in 2025.
- Its Debt to Equity was -$27.36 in Q3 2025, compared to $41.11 in Q2 2025 and $3.32 in Q1 2025.